Earnings History Data for Armata Pharmaceuticals, Inc. (ARMP) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals Inc. is a biotechnology company. It is focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. The company's principal product candidate consist AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. It is also developing and advancing a pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa. Armata Pharmaceuticals Inc., formerly known as AmpliPhi Biosciences Corporation, is based in Marina del Rey, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-11-2023	AH		ARMP	Armata Pharmaceuticals	93.00	-0.31	-0.33	0.00	Armata Pharmaceuticals GAAP EPS of -$0.86, revenue of $1.2M [11/14/2023 5:11 PM]	2.24	-0.44 (-16.42%)	2.47	-0.21 (-7.84%)	0.83 - 5.26	35,679	10,000	172
Armata Pharmaceuticals GAAP EPS of -$0.86, revenue of $1.2M [11/14/2023 5:11 PM]
14-08-2023	PM		ARMP	Armata Pharmaceuticals	146.00	-0.28	-0.35	0.00	Armata Pharmaceuticals GAAP EPS of -$0.17, revenue of $0.98M [8/14/2023 9:41 AM]	4.15	-0.20 (-4.60%)	0.0	0.0 (0.00%)	0.83 - 5.26	268,796	140,000	0
Armata Pharmaceuticals GAAP EPS of -$0.17, revenue of $0.98M [8/14/2023 9:41 AM]
10-11-2021	AH		ARMP	Armata Pharmaceuticals	95.00	-0.22	-0.26	0.00	Armata Pharmaceuticals EPS beats by $0.04, beats on revenue [11/10/2021 4:58 PM]	3.36	-0.27 (-7.44%)	3.36	-0.27 (-7.44%)	2.56 - 10.48	5,683	90,000	1,002
Armata Pharmaceuticals EPS beats by $0.04, beats on revenue [11/10/2021 4:58 PM] Armata Pharmaceuticals Announces Third Quarter Results and Provides General Corporate Update [Nov-10-21 04:05PM]
13-05-2021	AH	4:05 PM ET (May 13)	ARMP	Armata Pharmaceuticals, Inc.	101.26	-0.27	-0.28	-0.49	Armata Pharmaceuticals EPS beats by $0.05 [5/13/2021 5:18 PM]	3.92	0.03 (0.77%)	0.0	0.0 (0.00%)	2.56 - 10.48	3,795	10,000	0
Armata Pharmaceuticals EPS beats by $0.05 [5/13/2021 5:18 PM] SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Armata Pharmaceuticals Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors [May-13-21 10:45AM] Armata Pharmaceuticals Announces First Quarter Results and Provides General Corporate Update [May-13-21 04:05PM]
18-03-2021	AH	4:05 PM ET (Mar 18)	ARMP	Armata Pharmaceuticals, Inc.	114.17	-0.36	0.00	-0.48	Armata Pharmaceuticals EPS misses by $0.08, beats on revenue [3/18/2021 4:31 PM]	5.49	0.03 (0.55%)	6.29	0.78 (14.16%)	2.56 - 10.48	16,267	30,000	9,314
Armata Pharmaceuticals EPS misses by $0.08, beats on revenue [3/18/2021 4:31 PM] Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $20 Million Private Placement with Innoviva [Mar-17-21 04:01PM] Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Results and Provides General Corporate Update [Mar-18-21 04:05PM]